Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 4.581B
December 31, 2024 4.873B
December 31, 2023 6.606B
December 31, 2022 9.475B
December 31, 2021 5.872B
December 31, 2020 8.707B
December 31, 2019 6.340B
December 31, 2018 5.041B
December 31, 2017 5.383B
December 31, 2016 6.354B
December 31, 2015 8.888B
December 31, 2014 7.099B
December 31, 2013 9.532B
December 31, 2012 7.012B
December 31, 2011 9.275B
December 31, 2010 9.917B
December 31, 2009 11.21B
December 31, 2008 9.877B
Date Value
December 31, 2007 9.967B
December 31, 2006 5.950B
December 31, 2005 8.985B
December 31, 2004 7.639B
December 31, 2003 6.479B
December 31, 2002 3.975B
December 31, 2001 3.371B
December 31, 2000 5.366B
December 31, 1999 3.886B
December 31, 1998
December 31, 1997
December 31, 1996
December 31, 1995
June 30, 1994
June 30, 1993
June 30, 1992 3.328B
June 30, 1991 3.452B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
AstraZeneca PLC 5.741B
Eli Lilly & Co. 7.268B
Merck & Co., Inc. 14.69B
Pfizer Inc. 13.60B
Sanofi 9.013B